The outsiders

Emerging roles of ectonucleotidases in inflammation

Csaba Szabo, Pal Pacher

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Research on the biological roles of ectonucleoidases has revealed that CD73, an ecto-5′ nucleotidase, plays a special role in the extracellular conversion of adenosine monophosphate to adenosine - specifically, as a checkpoint that determines whether the extracellular environment is proinflammatory (characterized by adenosine 5′-triphosphate-mediated responses) or anti-inflammatory (adenosine-mediated responses). Inactivating or inhibiting CD73 attenuates the extracellular formation of adenosine, exacerbating the severity of various inflammatory diseases. In this issue of Science Translational Medicine, Flögel and colleagues showed that CD73 can be pharmacologically exploited to convert an inactive adenosine precursor to an active, anti-inflammatory adenosine analog. In addition to attenuating inflammation associated with collagen-induced arthritis in a mouse model, this prodrug approach was site-selective, because the metabolic conversion relies on CD73, which is up-regulated in the inflammatory locus (the joint).

Original languageEnglish (US)
Article number146ps14
JournalScience Translational Medicine
Volume4
Issue number146
DOIs
StatePublished - Aug 8 2012

Fingerprint

Adenosine
Inflammation
Anti-Inflammatory Agents
5'-Nucleotidase
Experimental Arthritis
Translational Medical Research
Prodrugs
Adenosine Triphosphate
Joints
ectoATPase
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The outsiders : Emerging roles of ectonucleotidases in inflammation. / Szabo, Csaba; Pacher, Pal.

In: Science Translational Medicine, Vol. 4, No. 146, 146ps14, 08.08.2012.

Research output: Contribution to journalArticle

@article{5b255d3183cf4d93ba39879a3b0688c8,
title = "The outsiders: Emerging roles of ectonucleotidases in inflammation",
abstract = "Research on the biological roles of ectonucleoidases has revealed that CD73, an ecto-5′ nucleotidase, plays a special role in the extracellular conversion of adenosine monophosphate to adenosine - specifically, as a checkpoint that determines whether the extracellular environment is proinflammatory (characterized by adenosine 5′-triphosphate-mediated responses) or anti-inflammatory (adenosine-mediated responses). Inactivating or inhibiting CD73 attenuates the extracellular formation of adenosine, exacerbating the severity of various inflammatory diseases. In this issue of Science Translational Medicine, Fl{\"o}gel and colleagues showed that CD73 can be pharmacologically exploited to convert an inactive adenosine precursor to an active, anti-inflammatory adenosine analog. In addition to attenuating inflammation associated with collagen-induced arthritis in a mouse model, this prodrug approach was site-selective, because the metabolic conversion relies on CD73, which is up-regulated in the inflammatory locus (the joint).",
author = "Csaba Szabo and Pal Pacher",
year = "2012",
month = "8",
day = "8",
doi = "10.1126/scitranslmed.3004378",
language = "English (US)",
volume = "4",
journal = "Science Translational Medicine",
issn = "1946-6234",
publisher = "American Association for the Advancement of Science",
number = "146",

}

TY - JOUR

T1 - The outsiders

T2 - Emerging roles of ectonucleotidases in inflammation

AU - Szabo, Csaba

AU - Pacher, Pal

PY - 2012/8/8

Y1 - 2012/8/8

N2 - Research on the biological roles of ectonucleoidases has revealed that CD73, an ecto-5′ nucleotidase, plays a special role in the extracellular conversion of adenosine monophosphate to adenosine - specifically, as a checkpoint that determines whether the extracellular environment is proinflammatory (characterized by adenosine 5′-triphosphate-mediated responses) or anti-inflammatory (adenosine-mediated responses). Inactivating or inhibiting CD73 attenuates the extracellular formation of adenosine, exacerbating the severity of various inflammatory diseases. In this issue of Science Translational Medicine, Flögel and colleagues showed that CD73 can be pharmacologically exploited to convert an inactive adenosine precursor to an active, anti-inflammatory adenosine analog. In addition to attenuating inflammation associated with collagen-induced arthritis in a mouse model, this prodrug approach was site-selective, because the metabolic conversion relies on CD73, which is up-regulated in the inflammatory locus (the joint).

AB - Research on the biological roles of ectonucleoidases has revealed that CD73, an ecto-5′ nucleotidase, plays a special role in the extracellular conversion of adenosine monophosphate to adenosine - specifically, as a checkpoint that determines whether the extracellular environment is proinflammatory (characterized by adenosine 5′-triphosphate-mediated responses) or anti-inflammatory (adenosine-mediated responses). Inactivating or inhibiting CD73 attenuates the extracellular formation of adenosine, exacerbating the severity of various inflammatory diseases. In this issue of Science Translational Medicine, Flögel and colleagues showed that CD73 can be pharmacologically exploited to convert an inactive adenosine precursor to an active, anti-inflammatory adenosine analog. In addition to attenuating inflammation associated with collagen-induced arthritis in a mouse model, this prodrug approach was site-selective, because the metabolic conversion relies on CD73, which is up-regulated in the inflammatory locus (the joint).

UR - http://www.scopus.com/inward/record.url?scp=84864880288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864880288&partnerID=8YFLogxK

U2 - 10.1126/scitranslmed.3004378

DO - 10.1126/scitranslmed.3004378

M3 - Article

VL - 4

JO - Science Translational Medicine

JF - Science Translational Medicine

SN - 1946-6234

IS - 146

M1 - 146ps14

ER -